AZ12253801 is an ATP-competitive IGF-1R tyrosine kinase inhibitor with antitumor activity; it inhibits IGF-1R-driven proliferation of 3T3 mouse fibroblasts (transfected with human IGF-1R) with an IC50 of 17 nmol/L and EGFR-induced cell proliferation with an IC50 of 440 nmol/L.